Event Recap: Second Annual Regulatory Science Doctoral Student Symposium

February 2020

On February 3rd, we hosted our second annual Regulatory Science Doctoral Student Symposium at Harvard Business School! It was a great day full of engaging presentations from trainees across disciplines. Presenters received excellent feedback from faculty mentors Ariel Stern, Florence Bourgeois, Josh Kreiger, Kyle Myers, and Frank David. Topics spanned everything from novel R&D platforms to clinical trial evaluation. See a list of presenters and topics below:

  • What are the payoffs from good science?: Incentives to meet methodological standards in clinical trials (Maryaline Catillon)
  • Parametric fitting of over 100,000 individual patient events fromclinical trials in oncology (Deborah Plana)
  • Midas touch or fool’s gold: Can pathology capture the $223 billion digital health market? (Richard Huang)
  • The safety and efficacy of off-label uses of cancer medicines in the US (Pragya Kakani)
  • Statistical regression model of new patient safety screening in the clinics (Shawn Kim)
  • Foundation-industry collaborations in clinical research: Exploratoryanalysis (Caroline Marra)
  • Uncertainty directed factorial clinical trials (Gopal Kotecha)
  • DUB target-class hit discovery by novel chemoproteomic platform (Adrian Chan)